Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Auris Medical Holding AG, Medical Devices Deals, 2012 to YTD 2018 10
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Auris Medical Acquires Intranasal Betahistine from Otifex Therapeutics 12
Venture Financing 13
Auris Medical Raises US$51 Million In Series C Financing 13
Partnerships 15
Auris Medical Extends its Drug Discovery Agreement with King’s College 15
Auris Medical Enters Into Agreement With Medidata Solutions 16
Equity Offering 17
Auris Medical Raises USD7 Million in Public Offering of Shares 17
Auris Medical to Raise Funds through Public Offering of shares 18
Auris Medical Raises USD5.5 Million in Public Offering of Shares 19
Auris Medical Raises USD10 Million in Public Offering of Units 20
Auris Medical to Raise up to USD35 Million in Public Offering of Shares 22
Auris Medical Raises USD25 Million in Public Offering of Shares 23
Auris Medical Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD60.7 Million 24
Auris Medical Holding AG – Key Competitors 26
Auris Medical Holding AG – Key Employees 27
Auris Medical Holding AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Aug 15, 2018: Auris Medical announces second quarter 2018 financial results 29
May 15, 2018: Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results 31
Mar 22, 2018: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results 33
Nov 28, 2017: Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update 35
Aug 10, 2017: Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results 37
May 11, 2017: Auris Medical Provides Business Update and Reports First Quarter 2017 Financial Results 39
Mar 14, 2017: Auris Medical Provides Business Update and Reports Full Year 2016 Financial Results 41
Corporate Communications 43
Sep 26, 2017: Auris Medical Provides Board of Directors Update 43
Product News 44
05/30/2018: Auris Medical to Host Key Opinion Leader Call Focused on AM-201 Program for Treating Major Side Effects of Antipsychotics on June 11, 2018 44
Mar 16, 2018: Auris’ tinnitus treatment fails late-stage study for the second time 45
02/03/2017: Auris Medical Expands Clinical Development Pipeline with Intranasal Betahistine for the Treatment of Meniere’s Disease and Vestibular Vertigo 46
Clinical Trials 47
Feb 07, 2018: Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Auris Medical Holding AG, Deals By Therapy Area, 2012 to YTD 2018 9
Auris Medical Holding AG, Medical Devices Deals, 2012 to YTD 2018 10
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Auris Medical Acquires Intranasal Betahistine from Otifex Therapeutics 12
Auris Medical Raises US$51 Million In Series C Financing 13
Auris Medical Extends its Drug Discovery Agreement with King's College 15
Auris Medical Enters Into Agreement With Medidata Solutions 16
Auris Medical Raises USD7 Million in Public Offering of Shares 17
Auris Medical to Raise Funds through Public Offering of shares 18
Auris Medical Raises USD5.5 Million in Public Offering of Shares 19
Auris Medical Raises USD10 Million in Public Offering of Units 20
Auris Medical to Raise up to USD35 Million in Public Offering of Shares 22
Auris Medical Raises USD25 Million in Public Offering of Shares 23
Auris Medical Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD60.7 Million 24
Auris Medical Holding AG, Key Competitors 26
Auris Medical Holding AG, Key Employees 27
Auris Medical Holding AG, Subsidiaries 28
List of Figures
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Auris Medical Holding AG, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer